208 related articles for article (PubMed ID: 29379303)
1. Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance.
Vert A; Castro J; Ribó M; Vilanova M; Benito A
Onco Targets Ther; 2018; 11():221-237. PubMed ID: 29379303
[TBL] [Abstract][Full Text] [Related]
2. A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells.
Liscovitch M; Ravid D
Cancer Lett; 2007 Jan; 245(1-2):350-2. PubMed ID: 16504380
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics analysis identifies mitochondria as therapeutic targets of multidrug-resistance in ovarian cancer.
Chen X; Wei S; Ma Y; Lu J; Niu G; Xue Y; Chen X; Yang F
Theranostics; 2014; 4(12):1164-75. PubMed ID: 25285166
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of Cytotoxicity of NCX4040, the Non-Steroidal Anti-Inflammatory NO-Donor, in Human Ovarian Cancer Cells.
Sinha BK; Tokar EJ; Bortner CD
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955744
[TBL] [Abstract][Full Text] [Related]
5. Solanum nigrum Unripe fruit fraction attenuates Adriamycin resistance by down-regulating multi-drug resistance protein (Mdr)-1 through Jak-STAT pathway.
Jagadeeshan S; David D; Jisha S; Manjula S; Asha Nair S
BMC Complement Altern Med; 2017 Jul; 17(1):370. PubMed ID: 28720093
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
Ong PS; Chan SY; Ho PC
Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
[TBL] [Abstract][Full Text] [Related]
7. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH
Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162
[TBL] [Abstract][Full Text] [Related]
8. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
[TBL] [Abstract][Full Text] [Related]
9. New findings on the antiproliferative activity of the silver(I) complex with 5-fluorouracil against human multi-resistant NCI/ADR-RES ovarian tumor cells.
Bormio Nunes JH; de Paiva PP; Ruiz ALTG; de Carvalho JE; Corbi PP
Toxicol In Vitro; 2019 Oct; 60():359-368. PubMed ID: 31238103
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Profiling Elucidates Cellular Responses to NCX4040 in Human Ovarian Tumor Cells: Implications in the Mechanisms of Action of NCX4040.
Sinha BK; Tokar EJ; Li J; Bushel PR
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612280
[TBL] [Abstract][Full Text] [Related]
11. Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy.
Baglo Y; Sorrin AJ; Pu X; Liu C; Reader J; Roque DM; Huang HC
Transl Oncol; 2021 Nov; 14(11):101198. PubMed ID: 34418731
[TBL] [Abstract][Full Text] [Related]
12. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
13. Transport, metabolism, cytotoxicity and effects of novel taxanes on the cell cycle in MDA-MB-435 and NCI/ADR-RES cells.
Ehrlichová M; Ojima I; Chen J; Václavíková R; Němcová-Fürstová V; Vobořilová J; Simek P; Horský S; Souček P; Kovář J; Brabec M; Gut I
Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1035-48. PubMed ID: 22855252
[TBL] [Abstract][Full Text] [Related]
14. pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1.
Benoit DS; Henry SM; Shubin AD; Hoffman AS; Stayton PS
Mol Pharm; 2010 Apr; 7(2):442-55. PubMed ID: 20073508
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
[TBL] [Abstract][Full Text] [Related]
16. Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer.
Wang X; Xu C; Hua Y; Sun L; Cheng K; Jia Z; Han Y; Dong J; Cui Y; Yang Z
J Exp Clin Cancer Res; 2016 Dec; 35(1):186. PubMed ID: 27906043
[TBL] [Abstract][Full Text] [Related]
17. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells.
Li Y; Guo Y; Feng Z; Bergan R; Li B; Qin Y; Zhao L; Zhang Z; Shi M
Nutr Cancer; 2019; 71(6):1007-1018. PubMed ID: 31032633
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10.
Varma RR; Hector SM; Clark K; Greco WR; Hawthorn L; Pendyala L
Oncol Rep; 2005 Oct; 14(4):925-32. PubMed ID: 16142353
[TBL] [Abstract][Full Text] [Related]
20. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
